2025 Retina Update, Part 1: Injectables in the Medical Retina Space

Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related macular degeneration (AMD) therapies, private equity acquisitions, and the new drug pipeline. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Episode metadata supplied by the publisher feed · Published Jan 23, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

2025 Retina Update, Part 1: Injectables in the Medical Retina Space

0:00 43:39

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Experts InSight?

This episode is 43 minutes long.

When was this Experts InSight episode published?

This episode was published on January 23, 2025.

Can I download this Experts InSight episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!